Latest News & Features
Americas
US-based Allele Biotechnology & Pharmaceuticals, a preclinical-stage biopharmaceutical company, has teamed up with a scientific e-commerce marketplace network in efforts to develop nanoantibodies for therapeutic applications. 5 December 2018
Big Pharma
The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage. 5 December 2018
Americas
German pharmaceutical company Boehringer Ingelheim has signed a research collaboration and licence agreement with French and Canadian biopharmaceutical business Domain Therapeutics. 4 December 2018
Americas
GSK has agreed to buy US oncology company Tesaro for $5.1 billion, in a move designed to strengthen its anti-cancer offering. 3 December 2018
Americas
AbbVie has granted Pfizer a non-exclusive global licence to its Humira IP, as announced on Friday, November 30. 3 December 2018
Big Pharma
Proposed amendments to the EU’s supplementary protection certificate manufacturing waiver risk “further disincentivising investment” in Europe, according to the European Federation of Pharmaceutical Industries and Associations. 30 November 2018
Americas
The University of Wisconsin’s licensing arm has been ordered to pay Washington University $31.6 million in a fight over patent licensing relating to one of AbbVie’s kidney drugs. 30 November 2018
Biotechnology
The National Health Service England is set to make record-breaking savings after negotiating deals with five manufacturers of low-cost biosimilar versions of the NHS's most expensive drug. 29 November 2018
Big Pharma
The US Food and Drug Administration has granted Pfizer paediatric exclusivity for Lyrica, extending the period of US market exclusivity for the drug by six months. 29 November 2018
Big Pharma
Japan-based Takeda Pharmaceutical has persuaded the European Union Intellectual Property Office that an applied-for trademark would be confused with its own earlier-registered mark 28 November 2018